Compassionate Use of Ropeginterferon-Alfa-2b/P1101 for Treatment of High Risk Polycythemia Vera and Essential Thrombocythemia Patients Previously Controlled on Pegylated Interferon-Alfa-2a/Pegasys®

被引：3
|
作者：
Gilreath, Jeffrey A. [1 ]
Tashi, Tsewang [2 ]
Kim, Soo Jin [3 ]
Hickman, Kimberly [4 ]
Prchal, Josef T. [3 ]
机构：
[1] Univ Utah, Huntsman Canc Inst, Dept Pharmacotherapy, Park City, UT USA
[2] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[3] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA
[4] Univ Utah, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116852
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5459
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGASYS) Therapy Renders High Clinical and Molecular Response Rates in Patients with Essential Thrombocythemia (ET) and Polycythemia VERA (PV)
    Quintas-Cardania, Alfonso
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Richie, Marie Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2008, 112 (11) : 246 - 246
  • [2] Ropeginterferon alfa-2b for the treatment of patients with polycythemia vera
    Wagner, S. M.
    Melchardt, I
    Greil, R.
    [J]. DRUGS OF TODAY, 2020, 56 (03) : 195 - 202
  • [3] Clinical Benefit of Ropeginterferon Alfa 2b (P1101) in Patients with Myelofibrosis
    Palmer, Jeanne
    Kosiorek, Heidi E.
    Zimmerman, Craig
    Zagrijtschuk, Oleh
    Camoriano, John
    Mesa, Ruben A.
    [J]. BLOOD, 2018, 132
  • [4] Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
    Yacoub, Abdulraheem
    Mascarenhas, John
    Kosiorek, Heidi
    Prchal, Josef T.
    Berenzon, Dmitry
    Baer, Maria R.
    Ritchie, Ellen
    Silver, Richard T.
    Kessler, Craig
    Winton, Elliott
    Finazzi, Maria Chiara
    Rambaldi, Alessandro
    Vannucchi, Alessandro M.
    Leibowitz, David
    Rondelli, Damiano
    Arcasoy, Murat O.
    Catchatourian, Rosalind
    Vadakara, Joseph
    Rosti, Vittorio
    Hexner, Elizabeth
    Kremyanskaya, Marina
    Sandy, Lonette
    Tripodi, Joseph
    Najfeld, Vesna
    Farnoud, Noushin
    Papaemmanuil, Elli
    Salama, Mohamed
    Singer-Weinberg, Rona
    Rampal, Raajit
    Goldberg, Judith D.
    Barbui, Tiziano
    Mesa, Ruben
    Dueck, Amylou C.
    Hoffman, Ronald
    [J]. BLOOD, 2019, 134 (18) : 1498 - 1509
  • [5] Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs Anagrelide as Second Line Therapy in Essential Thrombocythemia
    Masarova, Lucia
    Komatsu, Norio
    Gill, Harinder
    Jin, Jie
    Lee, Sung-Eun
    Hou, Hsin-An
    Sato, Toshiaki
    Qin, Albert
    Urbanski, Raymond
    Shih, Weichung
    Zagrijtschuk, Oleh
    Zimmerman, Craig
    Mesa, Ruben
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S405 - S405
  • [6] Pegylated interferon alfa-2a is effective and decreases LDH levels in patients with essential thrombocythemia and polycythemia vera
    Ekinci, O.
    [J]. LEUKEMIA RESEARCH, 2019, 85 : S27 - S27
  • [7] Ropeginterferon Alfa-2b Blunts Hyperactive JAK2 Activity in Polycythemia Vera and Essential Thrombocythemia
    Song, Jihyun
    Prchal, Josef T.
    [J]. BLOOD, 2023, 142
  • [8] Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide as Second Line Therapy in Essential Thrombocythemia
    Mesa, Ruben
    Komatsu, Norio
    Gill, Harinder
    Jin, Jie
    Lee, Sung-Eun
    Hou, Hsin-An
    Sato, Toshiaki
    Qin, Albert
    Urbanski, Raymond
    Shih, Weichung
    Zagrijtschuk, Oleh
    Zimmerman, Craig
    Verstovsek, Srdan
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S342 - S342
  • [9] Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Manshouri, Taghi
    Luthra, Rajyalakshmi
    Estrov, Zeev
    Pierce, Sherry
    Richie, Mary Ann
    Borthakur, Gautam
    Konopleva, Marina
    Cortes, Jorge
    Verstovsek, Srdan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (32) : 5418 - 5424
  • [10] Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses
    Tashi, Tsewang
    Swierczek, Sabina
    Kim, Soo Jin
    Salama, Mohamed E.
    Song, Jihyun
    Heikal, Nahla
    King, Katherine Y.
    Hickman, Kim
    Litton, Scott
    Prchal, Josef T.
    [J]. LEUKEMIA, 2018, 32 (08) : 1830 - 1833
12345